NYSE:HR - Healthcare Realty Trust Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $29.52 +0.13 (+0.44 %) (As of 09/20/2018 12:13 PM ET)Previous Close$29.32Today's Range$29.21 - $29.5552-Week Range$26.09 - $33.98Volume27,672 shsAverage Volume554,045 shsMarket Capitalization$3.76 billionP/E Ratio19.14Dividend Yield4.00%Beta0.15 Company ProfileDiscussionAnalyst RatingsChartDividend HistoryEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of June 30, 2018, the Company owned 201 real estate properties in 27 states totaling 14.9 million square feet and was valued at approximately $5.0 billion. The Company provided leasing and property management services to 11.2 million square feet nationwide. Receive HR News and Ratings via Email Sign-up to receive the latest news and ratings for HR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Real estate investment trusts Sub-IndustrySpecialized REITs SectorFinance SymbolNYSE:HR CUSIP42194610 Webwww.healthcarerealty.com Phone615-269-8175 Debt Debt-to-Equity Ratio0.76 Current Ratio0.11 Quick Ratio0.11 Price-To-Earnings Trailing P/E Ratio19.14 Forward P/E Ratio18.57 P/E Growth4.73 Sales & Book Value Annual Sales$424.50 million Price / Sales8.71 Cash Flow$1.2874 per share Price / Cash22.93 Book Value$14.33 per share Price / Book2.06 Profitability EPS (Most Recent Fiscal Year)$1.53 Net Income$23.09 million Net Margins2.95% Return on Equity0.72% Return on Assets0.41% Miscellaneous Employees273 Outstanding Shares125,230,000Market Cap$3.76 billion Healthcare Realty Trust (NYSE:HR) Frequently Asked Questions What is Healthcare Realty Trust's stock symbol? Healthcare Realty Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "HR." How often does Healthcare Realty Trust pay dividends? What is the dividend yield for Healthcare Realty Trust? Healthcare Realty Trust announced a quarterly dividend on Tuesday, July 31st. Stockholders of record on Wednesday, August 15th will be given a dividend of $0.30 per share on Thursday, August 30th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 4.10%. The ex-dividend date is Tuesday, August 14th. View Healthcare Realty Trust's Dividend History. How were Healthcare Realty Trust's earnings last quarter? Healthcare Realty Trust Inc (NYSE:HR) released its quarterly earnings data on Thursday, August, 2nd. The real estate investment trust reported $0.30 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.40 by $0.10. The real estate investment trust had revenue of $111.60 million for the quarter, compared to the consensus estimate of $111 million. Healthcare Realty Trust had a return on equity of 0.72% and a net margin of 2.95%. The business's revenue was up 6.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.39 earnings per share. View Healthcare Realty Trust's Earnings History. When is Healthcare Realty Trust's next earnings date? Healthcare Realty Trust is scheduled to release their next quarterly earnings announcement on Wednesday, November, 7th 2018. View Earnings Estimates for Healthcare Realty Trust. What price target have analysts set for HR? 8 brokers have issued 1-year target prices for Healthcare Realty Trust's stock. Their forecasts range from $25.00 to $34.00. On average, they anticipate Healthcare Realty Trust's share price to reach $29.25 in the next twelve months. This suggests that the stock has a possible downside of 0.2%. View Analyst Price Targets for Healthcare Realty Trust. What is the consensus analysts' recommendation for Healthcare Realty Trust? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Healthcare Realty Trust in the last year. There are currently 7 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Healthcare Realty Trust. What are Wall Street analysts saying about Healthcare Realty Trust stock? Here are some recent quotes from research analysts about Healthcare Realty Trust stock: 1. According to Zacks Investment Research, "Healthcare Realty Trust is a real estate investment trust that integrates owning, managing and developing income-producing real estate properties associated with the delivery of healthcare services throughout the United States. " (8/10/2018) 2. Cantor Fitzgerald analysts commented, "HR reported in-line 4Q17 results and expects more capital recycling in 2018. The company also started a major development in Seattle. 4Q17 revenue was $107.7 million vs. our $111.4 million estimate, and 4Q17 normalized FFO was $0.38 vs. our $0.39 estimate." (2/14/2018) Who are some of Healthcare Realty Trust's key competitors? Some companies that are related to Healthcare Realty Trust include Vornado Realty Trust (VNO), Alexandria Real Estate Equities (ARE), Gecina (GECFF), ANNALY Cap Mgmt/SH (NLY), HCP (HCP), Mid-America Apartment Communities (MAA), Klepierre (KLPEF), Extra Space Storage (EXR), Regency Centers (REG), SINO Ld Ltd/S (SNLAY), UDR (UDR), Duke Realty (DRE), Iron Mountain (IRM), Federal Realty Investment Trust (FRT) and AGNC Investment (AGNC). Who are Healthcare Realty Trust's key executives? Healthcare Realty Trust's management team includes the folowing people: Mr. Todd J. Meredith, Pres, CEO & Director (Age 43)Mr. James Christopher Douglas, Exec. VP & CFO (Age 42)Mr. Robert E. Hull, Exec. VP of Investments (Age 46)Mr. John M. Bryant Jr., Exec. VP & Gen. Counsel (Age 51)Mr. B. Douglas Whitman II, Sr. VP of Fin. & Treasurer (Age 49) Has Healthcare Realty Trust been receiving favorable news coverage? Media stories about HR stock have trended somewhat positive recently, Accern reports. Accern rates the sentiment of news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Healthcare Realty Trust earned a media and rumor sentiment score of 0.18 on Accern's scale. They also gave news stories about the real estate investment trust an impact score of 46.57 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days. View Recent Headlines for Healthcare Realty Trust. Who are Healthcare Realty Trust's major shareholders? Healthcare Realty Trust's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.12%), FMR LLC (4.67%), Morgan Stanley (3.94%), Northern Trust Corp (2.83%), Resolution Capital Ltd (2.54%) and Channing Capital Management LLC (1.78%). Company insiders that own Healthcare Realty Trust stock include Bruce D Sullivan, David R Emery, John Knox Singleton, John M Bryant Jr, Robert E Hull and Todd J Meredith. View Institutional Ownership Trends for Healthcare Realty Trust. Which major investors are selling Healthcare Realty Trust stock? HR stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Cbre Clarion Securities LLC, Russell Investments Group Ltd., NN Investment Partners Holdings N.V., Standard Life Aberdeen plc, Macquarie Group Ltd., Federated Investors Inc. PA and Bank of America Corp DE. Company insiders that have sold Healthcare Realty Trust company stock in the last year include John Knox Singleton, John M Bryant Jr, Robert E Hull and Todd J Meredith. View Insider Buying and Selling for Healthcare Realty Trust. Which major investors are buying Healthcare Realty Trust stock? HR stock was purchased by a variety of institutional investors in the last quarter, including Resolution Capital Ltd, Citadel Advisors LLC, Voya Investment Management LLC, BlackRock Inc., Channing Capital Management LLC, Gateway Investment Advisers LLC, Sit Investment Associates Inc. and Perpetual Ltd. Company insiders that have bought Healthcare Realty Trust stock in the last two years include David R Emery and John Knox Singleton. View Insider Buying and Selling for Healthcare Realty Trust. How do I buy shares of Healthcare Realty Trust? Shares of HR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Healthcare Realty Trust's stock price today? One share of HR stock can currently be purchased for approximately $29.30. How big of a company is Healthcare Realty Trust? Healthcare Realty Trust has a market capitalization of $3.76 billion and generates $424.50 million in revenue each year. The real estate investment trust earns $23.09 million in net income (profit) each year or $1.53 on an earnings per share basis. Healthcare Realty Trust employs 273 workers across the globe. How can I contact Healthcare Realty Trust? Healthcare Realty Trust's mailing address is 3310 WEST END AVE SUITE 700, NASHVILLE TN, 37203. The real estate investment trust can be reached via phone at 615-269-8175 or via email at [email protected] MarketBeat Community Rating for Healthcare Realty Trust (NYSE HR)Community Ranking: 1.8 out of 5 ()Outperform Votes: 221 (Vote Outperform)Underperform Votes: 378 (Vote Underperform)Total Votes: 599MarketBeat's community ratings are surveys of what our community members think about Healthcare Realty Trust and other stocks. Vote "Outperform" if you believe HR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 9/20/2018 by MarketBeat.com StaffFeatured Article: Are analyst ratings accurate?